Experimental Hematology

Papers
(The TQCC of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
1022 – ADVANCES IN CELLULAR BARCODING: EXPLORING HEMATOPOIETIC STEM CELLS AGEING AND METABOLIC FUNCTIONS IN LINEAGE SPECIFICATION71
1007 – GENOMIC REPETITIVE ELEMENTS SIGNAL SURFACE B2M TO BLOCK PHAGOCYTOSIS OF HSCS50
1030 – CELLULAR AND MOLECULAR MECHANISMS OF HEMATOPOIETIC LINEAGE CHOICE29
IFC Editorial Board27
3033 – DIFFERENTIAL RESPONSES AND RECOVERY DYNAMICS OF HAEMATOPOIETIC POPULATIONS FOLLOWING PLASMODIUM CHABAUDI INFECTION26
3194 – CLONAL HEMATOPOIESIS-ASSOCIATED DNMT3A MUTATIONS CAUSE INCREASED T CELL ACTIVATION AND DECREASED LEUKEMIC TUMOR BURDEN25
3215 – TWO NOVEL ENHANCERS OF CDKN1A ARE EPIGENETICALLY REGULATED BY THE CHROMATIN ASSEMBLY FACTOR 1 AND CEBPA IN ACUTE MYELOID LEUKEMIA22
3060 – BONE MARROW MESENCHYMAL STEM CELLS RELY ON VASCULAR CELL ADHESION MOLECULE-1 FOR SURVIVAL AND NICHE MAINTENANCE21
Neutrophil death-more than meets the eye20
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes20
RNA methylation: where to from here for hematologic malignancies?19
3010 – REJUVENATING BLOOD STEM CELLS EXTENDS LIFESPAN OF AGED IMMUNOCOMPROMISED MICE18
Corrigendum to A novel lymphoid progenitor cell population (LSKlow) is restricted by p18INK4c Experimental Hematology Volume 44 Issue 9 (2016), 874-885.e518
3077 – FUNCTIONAL AND MOLECULAR IDENTIFICATION OF A FETAL-ASSOCIATED TUMOR SUPPRESSOR AXIS: ABROGATION OF MLL-ENL DRIVEN ACUTE MYELOID LEUKEMIA18
3136 – LOSS OF CD36 EXPRESSION HAS LIMITED IMPACT ON NORMAL HEMATOPOIESIS17
2019 – DURING AGEING, THE HEMATOPOIETIC STEM CELL GENOME IS PROTECTED BY DORMANCY, NOT APOPTOSIS.17
3116 – MITOCHONDRIAL FUSION AGONISTS IMPROVE EXPANDED CORD BLOOD HEMATOPOIETIC STEM AND PROGENITOR CELLS FUNCTION IN VIVO16
3016 – MYCT1 CONTROLS HUMAN HEMATOPOIETIC STEM CELL FUNCTION BY MODERATING ENDOCYTOSIS AND ENVIRONMENTAL SENSING15
3163 – MODULATION OF RNA POLYMERASE II ACTIVITY REGULATES HUMAN HSC SELF-RENEWAL15
1022 – GENE THERAPY FOR BETA-THALASSEMIA: FROM THE BENCH TO THE BEDSIDE AND BACK15
3054 – CROSSTALK AT THE MATERNAL-FETAL INTERFACE CONSTRAINS FETAL HEMATOPOIETIC STEM AND PROGENITOR CELL RESPONSE TO INFLAMMATION.15
Corrigendum to ’ 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9’ [Volume 114, October 2022, Pages 43-53.e2]15
1014 – CELLULAR SENESCENCE: AN UNINTENDED TWIST FOR GENE AND CELL THERAPY APPLICATIONS14
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs14
3219 – RNA DEADENYLATION SUBUNIT CNOT3 PROMOTES MYELOID LEUKEMIA BY DRIVING TRANSLATION OF ONCOGENIC TARGETS13
Corrigendum to <‘Novel therapeutic strategies for multiple myeloma’> <[Experimental Hematology 2015; 43: 732-741]>13
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage13
3059 – UNRAVELLING HUMAN HEMATOPOIETIC PROGENITOR CELL DIVERSITY THROUGH ASSOCIATION WITH INTRINSIC REGULATORY FACTORS13
3064 – ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION-MEDIATED RNA STABILITY CONTROL13
ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming12
Distinct transcriptional changes in hematopoietic progenitor subsets on LPS-induced emergency granulopoiesis12
3220 – THE BONE MARROW EXTRACELLULAR MATRIX REMODELLING DURING ACUTE MYELOID LEUKAEMIA12
3110 – EGFL7 IS IMPORTANT FOR CELL CYCLE REGULATION AND PROLIFERATION OF HSCS12
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis11
Effect of peritransplant measurable residual disease clearance in patients with myelodysplastic neoplasm: a referral center experience11
A new era of functional experimentation in human hematopoiesis and leukemia research11
Cover 2: Editorial Board11
Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis11
3040 – DRUG DISCOVERY FOR INHIBITORS OF PHAGOCYTOSIS FOR USE IN IMMUNE CYTOPENIAS10
3195 – LONG-TERM EX VIVO HEMATOPOIETIC STEM CELL (HSC) EXPANSION USING NOVEL BONE-LINING REINVIGORATING MESENCHYMAL STROMAL CELLS (RMSCS)10
2024 – UNDERSTANDING HOW THE TISSUE MICROENVIRONMENT DIRECTS CELL FATE IN HAEMATOPOIETIC STEM AND PROGENITOR CELLS10
3006 – JAK2 PHOSPHORYLATES THE RNA PROCESSING PROTEIN HNRNPA1 TO REPRESS THE EXPRESSION OF RETROTRANSPOSONS AND PROTECT THE HAEMATOPOIETIC STEM CELL GENOME10
3124 – ANALYSIS OF TRANSCRIPTOMIC AND EPITRANSCRIPTOMIC EFFECTS OF THE ACUTE MEGAKARYOBLASTIC LEUKEMIA FUSION PROTEIN RBM15-MKL110
3141 – METABOLIC PROFILING OF HEMATOPOIETIC STEM CELLS (HSCS) FOLLOWING ACUTE INFLAMMATION10
3069 – EXPANSION OF A NOVEL LEUKEMIA STEM CELL-SUPPORTING CD55+ FIBROBLAST POPULATION IN THE PRELEUKEMIC BONE MARROW10
Integrins and their role in megakaryocyte development and function10
3174 – DOWNREGULATION OF MITOCHONDRIAL COMPLEX II IN MYELODYSPLASTIC SYNDROMES10
2019 – SYSTEMIC AND LOCAL REGULATION COOPERATES TO DETERMINE HEMATOPOIETIC STEM CELL NUMBERS10
Cover 2: Editorial Board9
2016 – CD32 ALLOWS CAPTURING BLOOD CELLS EMERGENCE IN SLOW MOTION DURING HUMAN EMBRYONIC DEVELOPMENT9
3131 – CROSS-SPECIES TRANSCRIPTOMICS REVEALS BIFURCATION POINT DURING THE ARTERIAL-TO-HEMOGENIC TRANSITION9
3054 – MESENCHYMAL STEM CELLS REVERSIBLY DE-DIFFERENTIATE MYOFIBROBLASTS TO FIBROBLAST-LIKE CELLS BY INHIBITING THE TGF-Β-SMAD2/3 PATHWAY9
Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes9
3065 – CRISPR MODELING OF ACUTE MYELOID LEUKEMIA MUTATIONS IN PRIMARY HEMATOPOIETIC STEM CELLS TO STUDY (PRE-)LEUKEMIA DEVELOPMENT9
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy8
Ontogeny, dynamics, and characteristics of neutrophils during the perinatal period8
3055 – MULTI-OMICS REVEALS AZACITIDINE PARTIALLY RESTORES THE HEMATOPOIESIS-SUPPORTIVE FUNCTIONS IN MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA8
3114 – FROM MECHANISMS OF LEUKAEMOGENIC DYSREGULATION TO NEW CANDIDATE THERAPEUTICS8
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms8
3192 – DEFINING THE MECHANISMS OF BST2 IN INFLAMMATION-DEPENDENT HEMATOPOIETIC STEM CELL ACTIVATION8
2004 – INFLAMMATORY FACTORS ORCHESTRATE THE BIRTH OF HSPCS THROUGH THEIR OSCILLATORY SIGNALING DYNAMICS8
3056 – VITAMIN C LIMITS MULTIPOTENT PROGENITOR SELF-RENEWAL AND CLONAL EXPANSION7
3011 – UNIQUE ROLES OF KMT2A FAMILY MEMBERS IN HEMATOPOIESIS AND LEUKEMIA7
3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS7
1024 – NICOTINAMIDE RIBOSIDE ENHANCES AMINO ACID CATABOLISM TO REJUVENATE OLD HEMATOPOIETIC STEM CELLS BY RESTORING THEIR METABOLISM AND PROTEOSTASIS7
Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia7
Immune control in acute myeloid leukemia7
3057 – MULTIOME ANALYSIS IDENTIFIES HSC SUBSETS WITH THYMIC REGENERATIVE CAPACITY7
2008 – SELF-RENEWAL OF LATE-STAGE ERYTHROID PROGENITORS7
3043 – FETAL EMERGENCY MYELOPOIESIS IS RESTRICTED BY MATERNAL INFLAMMATION.7
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing7
Building bones for blood and beyond: the growing field of bone marrow niche model development7
Generation of functionally distinct hemogenic endothelial cell populations from pluripotent stem cells7
3119 – DECIPHERING THE IMPACT OF TYPE 1 INTERFERON IN HUMAN CALR-MUTATED AND WILDTYPE HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MYELOPROLIFERATIVE NEOPLASMS VIA SINGLE-CELL MULTI-OMICS7
3097 – THE LONG NONCODING RNA ELDR AS A NEW THERAPEUTIC TOOL AGAINST HUMAN ACUTE MYELOID LEUKEMIA (AML)7
3042 – PRECISE INTRODUCTION OF SRSF2 P95H RECAPITULATES DISEASE PHENOTYPES AND GIVES INSIGHT INTO THE CELLULAR MECHANISM OF ACTION7
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment7
Macrophages form erythropoietic niches and regulate iron homeostasis to adapt erythropoiesis in response to infections and inflammation7
3108 – PHOSPHORYLATION OF RUNX1 PROMOTES MEGAKARYOCYTIC FATE IN MEGAKARYOCYTE-ERYTHROID PROGENITOR FATE SPECIFICATION6
3210 – BIOLOGY AND FUNCTION OF CIRCULAR PCMDT1 (CP1) IN CHRONIC MYELOID LEUKEMIA IN BLAST CRISIS (CML-BC)6
3204 – NK CELL-DEFECTS OCCURRING ALREADY AT THE PRE-MDS STAGE IN NUP98-HOXD13 TRANSGENIC MOUSE MODEL6
3104 – TRANSCRIPTIONAL AND FUNCTIONAL ANALYSIS OF MURINE FETAL LIVER HEMATOPOIETIC STEM CELLS AT SINGLE CELL RESOLUTION6
3027 – CASEIN KINASE II ALPHA (CK2A) DELETION AFFECTS MYELOID HEMATOPOIESIS IN CONDITIONAL KNOCKOUT MOUSE MODEL6
3073 – EARLY IDENTIFICATION OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE BY F-DEX ASSAY AND MURINE MODELS6
3190 – ACCOUNTING FOR BIOLOGICAL VARIATION IN SCRNA-SEQ QUALITY CONTROL METRICS RETAINS DISTINCT NICHE AND HEMATOPOIETIC CELL TYPES6
Inhibition of PAK1 generates an ameliorative effect on MPLW515L mouse model of myeloproliferative neoplasms by regulating the differentiation and survival of megakaryocytes6
3122 – SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIA5
3187 – INVESTIGATION OF THE THERAPEUTIC EFFECT OF A NOVEL SMALL MOLECULE INHIBITING YBX1 IN MYELOID MALIGNANCIES5
Analysis of risk factors for the early death of lymphocyte subsets in adult patients with secondary hemophagocytic lymphohistiocytosis5
3128 – IDENTIFICATION AND CHARACTERIZATION OF CD96+CD70+ LEUKEMIC STEM CELLS AND NICHE-MEDIATED RESISTANCE IN CBFA2T3-GLIS2 AMKL5
3012 – DEEPLY QUIESCENT HEMATOPOIETIC STEM CELLS MAINTAIN FUNCTION BY GPRASP2-MEDIATED CELL-SURFACE RECEPTOR DEGRADATION5
1008 – UNIFIED SINGLE-CELL METHODS SORT DIVERGENT FATES THROUGH GENE REGULATION5
3110 – EX VIVO CRISPR-BASED SICKLE CELL MODELING5
3215 – A SINGLE-CELL EXPRESSION ATLAS OF HUMAN AML LEUKEMIA-INITIATING CELLS UNRAVELS THE CONTRIBUTION OF HIF PATHWAY AND ITS THERAPEUTIC POTENTIAL5
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study5
1002 – BONE MARROW FAILURE AND CLONAL EVOLUTION5
Development and aging of resident endothelial stem cells in pre-existing blood vessels5
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia5
3209 – SINGLE-CELL PROFILING OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA REVEALS A GRADUAL TRANSITION FROM PRE-LEUKEMIA TO LEUKEMIA5
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro5
3222 – THE SURROGATE HEMATOPOIETIC STEM CELL NICHE AS A TOOL TO UNDERSTAND HEMATOPOIETIC STEM CELL EXPANSION5
3082 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AS A NICHE FACTOR THAT REGULATES HSC QUIESCENCE5
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV5
Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis5
2004 – A SINGLE-CELL PROTEOMICS BY MASS SPECTROMETRY BASED MAP OF THE HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL COMPARTMENT4
TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells4
1004 – REGULATION OF THE HEMATOPOIETIC STEM CELL POOL BY C-KIT-ASSOCIATED TROGOCYTOSIS4
2011 – SUBCLONAL MUTATIONS ALTER CORE SIGNALLING NODES AND DRUG RESPONSES IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA4
3002 – CIRCADIAN CUES REPROGRAM METABOLIC PATHWAYS IN LONG-TERM REPOPULATING HEMATOPOIETIC STEM CELLS4
C-COUNT: a convolutional neural network–based tool for automated scoring of erythroid colonies4
In Memoriam: Prof. Vittorio Rizzoli, The visionary who built experimental hematology in Italy4
3198 – IGH TRANSLOCATIONS IN CHINESE PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA: CLINICOPATHOLOGIC CHARACTERISTICS AND GENETIC PROFILE4
1032 – STEM CELLS IN HUMAN AML4
3076 – CHARACTERIZATION OF THE ROLE OF EIF4A IN THE RESISTANCE OF ACUTE MYELOID LEUKEMIA TO CHEMOTHERAPY AND TARGETED THERAPIES4
Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells4
3048 – MECHANISMS AND PROGNOSIS OF A20 MUTATION AND ABNORMAL EXPRESSION IN T-CELL MALIGNANCIES4
3044 – IDENTIFICATION OF SURFACE MARKERS OF MALIGNANT CELL STATES IN ACUTE MYELOID LEUKEMIA USING EXPLAINABLE MACHINE LEARNING4
Mtg16 NHR1 mutations cause defects in lymphopoiesis and the response to anemia4
3221 – KLF4/MLL3 CAMPASS COMPLEX TRANSCRIPT REGULATING NRBP2 TO ELIMINATE AML CELLS4
2023 – INTRA- AND EXTRACELLULAR PROTEOME DYNAMICS DURING NORMAL AND MALIGNANT HEMATOPOIETIC STEM CELL EXPANSION4
1016 – FINE-TUNING TPO-MPL ACTIVITY TO CONTROL HEMATOPOIESIS4
3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY4
3086 – THE ROLE OF DEVELOPMENTAL WNT SIGNALING IN ABERRANT ADULT HEMATOPOIESIS4
3120 – INVESTIGATING THE ROLE OF GPR56 IN ACUTE MYELOID LEUKAEMIA USING A TET-ON MODEL OF AN ACTIVATED GPR56 RECEPTOR IN HUMAN IPSC-DERIVED HAEMATOPOIETIC CELLS4
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils4
3150 – GATA2 DETERMINES HEMATOPOIETIC STEM/PROGENITOR CELL RESPONSES TO OPPORTUNISTIC FUNGAL INFECTION3
1018 – MALPS: A MASTER REGULATOR OF BONE MARROW MICROENVIRONMENT3
3029 – ISOFORM SPECIFIC ROLES FOR CD97 IN ACUTE MYELOID LEUKEMIA3
3093 – SUBTYPE-SPECIFIC INDUCTION OF MITOCHONDRIAL APOPTOSIS AS A NOVEL THERAPEUTIC OPTION IN HIGH-FATALITY PEDIATRIC LEUKEMIA3
Assay optimization for the objective quantification of human multilineage colony-forming units3
3122 – CUX1 LEVELS CONTROL HEMATOPOIETIC STEM CELL FATE AND PLASTICITY3
3090 – CLONAL RECONSTRUCTION FROM CO-OCCURRENCE OF VECTOR INTEGRATION SITES ALLOWS ACCURATE QUANTIFICATION OF EXPANDING CLONES IN VIVO3
Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization3
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice3
Cell-extrinsic factors contribute toward myeloid-biased expansion in Tet2-mutant clonal hematopoiesis3
3075 – DNMT3A LIMITS MYELOID SIGNALING RESPONSES IN T-CELL PROGENITORS DURING NORMAL AND LEUKEMIC DEVELOPMENT3
3068 – CRISPR SCREENING IN PRIMARY HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IDENTIFIES THE RNA HELICASE DDX6 AS A NOVEL HSC REGULATOR3
3177 – CLONAL HEMATOPOIESIS PROMOTES HEART FAILURE WITH PRESERVED EJECTION FRACTION3
3057 – HIGH SALT DIETS PROMOTE A TH17 CELL DRIVEN GUT-BONE AXIS TO REGULATE HAEMATOPOIESIS AND ATHEROSCLEROSIS3
Fetal allotransplant recipients are resistant to graft-versus-host disease3
3064 – AN ACTIVATED GPR56 RECEPTOR ENHANCES SURVIVAL OF HUMAN IPSC-DERIVED HAEMATOPOIETIC STEM/PROGENITOR CELLS3
3041 – CELLULAR MECHANISMS INVOLVED IN SERONEGATIVE HEMOLYTIC ANEMIAS3
3203 – IDENTIFICATION OF DIFFERENTIATION ROOTS OF HEMATOPOIETIC STEM CELLS BY A PAIRED-DAUGHTER ASSAY COMBINED WITH MULTIPLE BARCODING3
3074 – GLOBAL EPIGENOMIC REGULATION OF GENE EXPRESSION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BY IKAROS3
3119 – IDENTIFICATION OF CULTURE CONDITIONS THAT SUSTAIN THE IN VIVO REGENERATIVE PROPERTIES OF A NEW SUBSET OF HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS3
Short Talk Presentations3
1005 – SWITCHING GENES ON AND OFF DURING HAEMATOPOIESIS3
Novel techniques to quantitatively assess age-dependent alterations in biophysical properties of HSPCs and bone marrow niche3
3111 – BCL11B ORCHESTRATES GENERATION OF LYMPHOID-PRIMED DEFINITIVE HEMATOPOIETIC PROGENITORS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS3
3023 – CHARACTERIZATION OF THE ONCOGENIC ACTIVITY OF TLX1 AND TLX3 TRANSCRIPTION COMPLEXES IN T-ALL3
1029 – ETIOLOGY, PATHOGENESIS AND CELL-OF-ORIGIN OF MLL-REARRANGED INFANT/PEDIATRIC B-CELL ALL3
2022 – CHARACTERIZING HETEROGENEITY IN HEALTHY AND MALIGNANT HEMATOPOIETIC HIERARCHIES USING SINGLE CELL PROTEOMICS3
Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs3
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent3
3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA3
Functional and molecular profiling of hematopoietic stem cells during regeneration3
3213 – DISSECTING THE BLOOD ECOSYSTEM IN SARS-COV-2 OMICRON PATIENTS3
3136 – RAMAN SPECTROSCOPY IMAGING TO TRACK ACTIVITY OF IMMUNE CELLS.3
3060 – PDGFRΒ+ CELLS PLAY A DUAL ROLE AS HEMATOPOIETIC PRECURSORS AND NICHE CELLS DURING MOUSE ONTOGENY3
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells3
3089 – ERK INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS3
3037 – POLYCOMB GROUP PROTEIN MEL18 REGULATES HEMATOPOIETIC STEM CELL BEHAVIORS VIA MODULATING THE EPIGENOME AND HIGHER ORDER CHROMATIN STRUCTURE2
2023 – CELLULAR BARCODING OF THE LEUKEMIC NICHE REVEALS AN APELIN-MEDIATED CLONAL EXPANSION OF NICHE ENDOTHELIAL AND MESENCHYMAL STROMAL CELLS2
3139 – THE ROLE OF MYELOID CELLS HARBORING CLONAL HEMATOPOIESIS MUTATIONS IN ALZHEIMER'S DISEASE2
3148 – EMP- AND HSC-DERIVED NEUTROPHILS DYNAMICALLY CONTRIBUTE TO THE DEVELOPING MOUSE HEMATOPOIETIC SYSTEM2
2022 – TRANSCRIPTION FACTOR REDISTRIBUTORS ACTUATE NON-CANONICAL GENE CIRCUITS TO DRIVE AML DIFFERENTIATION2
3148 – GENETICALLY ENGINEERED INDUCED PLURIPOTENT STEM CELLS (IPSC) FOR THE EFFICIENT GENERATION OF HYPOIMMUNOGENEIC CHIMERIC ANTIGEN RECEPTOR (CAR)-ENGINEERED T CELLS2
1018 – HETEROGENEITY AND FUNCTIONAL SPECIALIZATION OF THE BONE MICROVASCULATURE2
1023 – THE IMPORTANCE OF STEM CELL EXPANSION IN TOMORROW'S MEDICINE2
1007 – MAXIMIZING CELL DEATH IN LEUKEMIAS: BCL-2 AND BEYOND2
2016 – METALLOPROTEINASE INHIBITION REDUCES AML GROWTH, PREVENTS STEM CELL LOSS, AND IMPROVES CHEMOTHERAPY EFFECTIVENESS2
2001 – THE ENDOSOMAL ADAPTOR PROTEIN MYCT1 CONTROLS ENVIRONMENTAL SENSING IN HUMAN HEMATOPOIETIC STEM CELLS2
3007 – T-CELL MEDIATED STEM-LIKE PLASTICITY OF GERMINAL CENTER B CELLS2
The Akt–mTOR network at the interface of hematopoietic stem cell homeostasis2
3002 – DAMAGE-RESISTANT MYELOID-DERIVED SUPPRESSOR CELLS DRIVE THE RECOVERY AND REGENERATION OF THE BONE MARROW ENDOTHELIAL HEMATOPOIETIC NICHE BY ACTIVATING NOTCH SIGNALING2
Cohesin haploinsufficiency is tolerated in Cbfb::MYH11-driven murine acute myeloid leukemia2
3047 – A NAD+ METABOLIC CHECKPOINT REGULATES HEMATOPOIETIC STEM CELL ACTIVATION AND AGING2
2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.2
3106 – PROTEOMICS AND GENOMICS STUDIES REVEALED A NEW ROLE FOR MLL PARTIAL TANDEM DUPLICATION (PTD) IN MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML)2
Cover 2: Editorial Board2
1022 – THE DEVELOPMENTAL ORIGINS OF BLOOD AND BLOOD CANCER2
3068 – CBX7 INHIBITORS BLOCK CELL PROLIFERATION AND INDUCE DIFFERENTIATION OF ACUTE MYELOID AND LYMPHOBLASTIC LEUKEMIA CELLS2
3232- – INFLAMMATORY STRESS PROMOTES HETEROGENEOUS ACTIVATION OF IMMUNE RESPONSE PROGRAMS IN HUMAN HEMATOPOIETIC STEM CELLS2
3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS2
3223 – THE DEVELOPMENT OF A DIAGNOSTIC TOOL TO HELP PRIMARY CARE CLINICIANS MANAGE PATIENTS WITH SUSPECTED MYELOMA2
3184 – ONCOSTATIN M SIGNALING MEDIATES DNMT3A-MUTANT HEMATOPOIETIC STEM CELL FITNESS IN THE AGED BONE MARROW MICROENVIRONMENT2
Nucleic acid metabolism: the key therapeutic target for myeloid tumors2
3018 – THE BILE ACID RECEPTOR TGR5 REGULATES THE COMPOSITION AND HEMATOPOIETIC SUPPORT CAPACITY OF THE BONE MARROW MICROENVIRONMENT2
3200 – RENIN-ANGIOTENSIN SYSTEM INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS2
3061 – STROMAL CELL-TRIGGERED DOWNREGULATION OF THE NUCLEOPORIN (NUP) FAMILY DRIVES TRANSFORMATION OF MYELODYSPLASIA TO ACUTE MYELOID LEUKEMIA2
Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer2
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells2
Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia2
3021 – SINGLE-CELL RNASEQ REVEALS CELL ADHESION MOLECULE PROFILES OF SHORT-TERM AND LONG-TERM CORD BLOOD HEMATOPOIETIC STEM CELLS2
3095 – SEX-SPECIFIC DIFFERENCES IN PLATELET PARAMETERS AND THE UTILITY OF MEAN PLATELET VOLUME/ PLATELET COUNT RATIO IN DIAGNOSING IRON DEFICIENCY ANEMIA2
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone2
3179 – ID1 ABLATION RESCUES CLONAL HEMATOPOIESIS AND DELAYS DISEASE PROGRESSION IN TET2 NULL MICE2
1010 – CONVERGENT SOMATIC EVOLUTION FROM EARLY LIFE IN A GERMLINE RIBOSOMOPATHY2
3151 – THE ALTERNATIVE NUCLEOSOME REMODELING FACTOR COMPLEX SUSTAINS ACUTE MYELOID LEUKEMIA BY REGULATING THE ACCESSIBILITY OF INSULATOR REGIONS2
3177 – RUNX FACTORS LAUNCH T CELL AND INNATE LYMPHOID CELL PROGRAMS VIA DIRECT BINDING AND GENE NETWORK-BASED MECHANISMS2
3051 – HEMATOPOIETIC STEM CELLS DEPEND ON AUTOPHAGY TO MAINTAIN PROTEIN HOMEOSTASIS2
From Metcalf to myeloproliferative neoplasms – a personal journey2
Establishing a low-dose x-ray irradiation protocol for experimental acute graft-versus-host disease2
3081 – LCK DRUG TARGETING IN PAX5 REARRANGED CASES IN POOR RISK CHILDHOOD B-CELL PRECURSORS ACUTE LYMPHOBLASTIC LEUKAEMIA2
3004 – ACUTE MYELOID LEUKEMIA CELLS REQUIRE 18-CARBON LONG FATTY ACIDS FOR PROTEIN S-ACYLATION TO MAINTAIN MITOCHONDRIAL ACTIVITY AND METABOLIC PLASTICITY2
3106 – GENOME-WIDE CRISPR SCREENING IDENTIFIES THE E3 UBIQUITIN LIGASE HERC1 AS A MODULATOR OF THE RESPONSE TO NUCLEOSIDE ANALOGS IN ACUTE MYELOID LEUKEMIA2
A-to-I RNA editing and hematopoiesis2
3221 – INVESTIGATING THE ROLE OF UBIQUITIN E3 LIGASE, FBXO21, IN THE REGULATION OF CYTOKINE SIGNALING WITHIN ACUTE MYELOID LEUKEMIA2
3126 – PERSISTENT METABOLIC DEFLATION OF HEMATOPOIETIC STEM CELLS (HSCS) AFTER CHEMOTHERAPY CAUSES PREMATURE HEMATOPOIETIC AGEING1
2020 – PRECISE SINGLE-CELL TRANSCRIPTOMIC MAPPING OF NORMAL AND LEUKEMIC CELL STATES REVEALS UNCONVENTIONAL LINEAGE PRIMING IN ACUTE MYELOID LEUKEMIA1
CFU-S assay: a historical single-cell assay that offers modern insight into clonal hematopoiesis1
2024 – SPATIAL TRANSCRIPTOMICS CHARACTERIZE DYNAMIC AND POLARIZED NICHE CELLS AND SIGNALS FOR EMBRYONIC HEMATOPOIESIS1
Corrigendum to ‘3161 – CELLULAR AND MOLECULAR EFFECTS OF DMPGE₂ RADIOMITIGATION IN MOUSE AND HUMAN BONE MARROW CELLS IN VIVO USING C57BL/6 AND HUMANIZED NSG MOUSE MODELS OF ACUTE RADIATION SYNDROME’ [1
Metabolic regulation of erythrocyte development and disorders1
3104 – EARLY MOLECULAR STEPS IN HUMAN BONE MARROW STEM CELL DIFFERENTIATION TRAJECTORIES1
3145 – WHAT IS THE FUNCTION OF THE EPO-EPOR AXIS IN MATURE XENOPUS ERYTHROCYTES?1
3015 – COORDINATED REGULATION AT THE SYSTEMIC AND LOCAL LEVELS PLAYS A PIVOTAL ROLE IN DETERMINING HEMATOPOIETIC STEM CELL NUMBERS1
3047 – ROLE OF EPIGENETIC DYSFUNCTION IN CHRONIC NEUTROPHILIC LEUKEMIA1
3019 – SINGLE-CELL PROTEO-GENOMIC REFERENCE MAPS OF THE HEMATOPOIETIC SYSTEM ENABLE THE PURIFICATION AND MASSIVE PROFILING OF PRECISELY DEFINED CELL STATES1
3158 – FUNCTIONAL POTENTIAL OF FETAL LIVER HEMATOPOIETIC STEM CELLS IS MAINTAINED BY JAGGED1 ACTIVATION OF NOTCH SINGALING1
3109 – SPLICING AND TRANSCRIPTIONAL ELONGATION REGULATION OF HEMATOPOIETIC STEM AND PROGENITOR CELL EMERGENCE1
3043 – SEX-DEPENDENT NICHE RESPONSES MODULATE STEADY-STATE AND REGENERATIVE HEMATOPOIESIS1
3104 – FITNESS IS A BETTER PREDICTOR OF OUTCOMES IN CLONAL HEMOPOIESIS COMPARED TO CLONE SIZE1
A Tribute to Hal Broxmeyer (1944–2021)1
3159 – A SINGLE-CELL PROTEIN-TRANSCRIPTOME ATLAS OF HAEMATOPOIESIS ACROSS THE HUMAN LIFESPAN1
3195 – FISH IN COMBINATION WITH RT-PCR AIDS IN THE CLASSIFICATION OF B-OTHER ALL BY IMPROVING THE IDENTIFICATION OF THE ZNF384 REARRANGEMENT1
3062 – HIGH THROUGHPUT EPIGENOMIC PROFILING IN HEMATOPOIETIC STEM/PROGENITOR FATE COMMITMENT1
2015 – STRUCTURAL AND FUNCTIONAL ANALYSIS OF BONE MARROW STROMAL NETWORKS DURING CHEMOTHERAPY1
3086 – APOPTOTIC CELLS-DERIVED CD14(+) MICROPARTICLES PROMOTE THE PHAGOCYTIC ACTIVITY OF NEUTROPHILIC PRECURSOR CELLS IN THE PHAGOCYTOSIS OF APOPTOTIC CELLS1
3002 – TRANSCRIPTION FACTOR PROFILING REVEALS THAT CEBPA PROMOTES RIBOSOMAL RNA SYNTHESIS IN MYELOID PROGENITORS1
3044 – IP-10 LOSS MODULATES ERYTHROID CELL PRODUCTION IN MOUSE MODELS OF MYELOPROLIFERATIVE NEOPLASMS1
3118 – CHAPERONE-MEDIATED AUTOPHAGY MAINTAINS LEUKEMIC STEM CELLS1
VEGF, FGF2, and BMP4 regulate transitions of mesoderm to endothelium and blood cells in a human model of yolk sac hematopoiesis1
3058 – METABOLIC HETEROGENEITY IN HEMATOPOIETIC STEM AND PROGENITOR CELLS FUELS INNATE IMMUNITY1
3025 – UNCOVERING THE ROLE OF KDM5C IN NORMAL HEMATOPOIESIS1
3200 – DEVELOPMENTAL REGULATION OF ENDOTHELIAL-TO-HEMATOPOIETIC TRANSITION FROM INDUCED PLURIPOTENT STEM CELLS1
3124 – GRANULOCYTE COLONY-STIMULATING FACTOR MODIFIES THE IN VITRO DIFFERENTIATION OF HUMAN PRIMITIVE ERYTHROID PROGENITOR CELLS1
3055 – ENHANCING TRANSLATION FIDELITY EXTENDS HEMATOPOIETIC STEM CELL LONGEVITY1
2001 – BLOOD FLOW TRIGGERS MTORC1-DEPENDENT MITOCHONDRIAL REMODELING REQUIRED FOR HEMATOPOIETIC STEM CELL FATE1
Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies1
Lethal and sublethal effects of programmed cell death pathways on hematopoietic stem cells1
3143 – ACUTE HEMATOPOIETIC RESPONSE OF GRANULOCYTE COLONY-STIMULATING FACTOR EXPRESSION IN MEDAKA FISH1
IFC Editorial Board1
3175 – AN UNSUPERVISED INTEGRATION FRAMEWORK TO COMPREHENSIVELY CAPTURE HUMAN HEMATOPOIETIC STEM CELL VARIATION IDENTIFIES HALLMARK SIGNATURES WITH A LINK TO AGING1
3201 – MOLECULAR CHARACTERISTICS OF MALIGNANT HEMATOPOIETIC STEM CELLS IN ESSENTIAL THROMBOCYTHEMIA ACROSS DISTINCT DRIVER MUTATIONS1
3084 – CELL QUIESCENCE AND REPROGRAMMING ARE DISTINCTIVE FEATURES OF PRE-LEUKEMIC STEM CELLS IN B-ACUTE LYMPHOBLASTIC LEUKEMIA1
3038 – SCIMP PROMOTES TLR SIGNALING AND REGULATES FUNCTION IN HEMATOPOIETIC STEM CELLS1
3044 – CRISPR ACTIVATION SCREENS IDENTIFY CO-DRIVERS OF MALIGNANT HAEMATOPOIESIS IN A DNMT3A MUTANT BACKGROUND1
3192 – CASPASE-1 AFFECTS ACTIVATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AFTER CHEMOTHERAPY1
Epidemiology of Chronic Lymphocytic Leukemia in Sardinia, Italy (1974–2003)1
0.24783992767334